We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$48.6B
AUM Growth
-$4.2B
Cap. Flow
+$3.6B
Cap. Flow %
7.4%
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
963
Reduced
740
Closed
743

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$340M
2
BAC icon
Bank of America
BAC
+$302M
3
CI icon
Cigna
CI
+$294M
4
TSM icon
TSMC
TSM
+$275M
5
UNP icon
Union Pacific
UNP
+$256M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$426M
2
SPGI icon
S&P Global
SPGI
+$413M
3
BKNG icon
Booking.com
BKNG
+$264M
4
CMCSA icon
Comcast
CMCSA
+$256M
5
TFX icon
Teleflex
TFX
+$241M

Sector Composition

Rank Sector Weight
1 Healthcare 17.59%
2 Financials 16.96%
3 Technology 16.37%
4 Consumer Discretionary 9.32%
5 Industrials 7.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMGMW
1601
CALL
DELISTED
Priveterra Acquisition Corp. II Warrant to purchase Class A common stock
PMGMW
$3.47M 0.01%
349,995
AVD icon
1602
American Vanguard Corp
AVD
$65.5M
$3.47M 0.01%
+155,031
New +$3.47M
HAACW
1603
CALL
DELISTED
Health Assurance Acquisition Corp. Warrants
HAACW
$3.46M 0.01%
349,998
ABT icon
1604
Abbott
ABT
$188B
$3.44M 0.01%
31,698
-538,568
-94% -$61.2M
TEAM icon
1605
Atlassian
TEAM
$38.5B
$3.44M 0.01%
18,357
-59,922
-77% -$12.8M
HCARW
1606
CALL
DELISTED
Healthcare Services Acquisition Corporation Warrant
HCARW
$3.44M 0.01%
349,450
SOC.WS
1607
CALL
DELISTED
Sable Offshore Corp. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
SOC.WS
$3.44M 0.01%
351,195
ILF icon
1608
iShares Latin America 40 ETF
ILF
$3.81B
$3.44M 0.01%
+152,400
New +$4.06M
WAT icon
1609
Waters Corp
WAT
$40.4B
$3.43M 0.01%
10,375
+5,812
+127% +$1.84M
QDROW
1610
CALL
DELISTED
Quadro Acquisition One Corp. Warrant
QDROW
$3.43M 0.01%
349,421
EGIO
1611
DELISTED
Edgio, Inc. Common Stock
EGIO
$3.43M 0.01%
37,115
-9,374
-20% -$1.35M
FWAC
1612
DELISTED
Fifth Wall Acquisition Corp. III Class A Ordinary Shares
FWAC
$3.43M 0.01%
352,419
CNXC icon
1613
Concentrix
CNXC
$1.56B
$3.42M 0.01%
25,182
-48,241
-66% -$7.26M
FLYA.WS
1614
CALL
DELISTED
SOAR Technology Acquisition Corp. Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
FLYA.WS
$3.42M 0.01%
335,686
ARTEW
1615
CALL
DELISTED
Artemis Strategic Investment Corporation Warrant
ARTEW
$3.4M 0.01%
340,000
-12,163
-3% -$2.27K
KIIIW
1616
CALL
DELISTED
Kismet Acquisition Three Corp. Warrant
KIIIW
$3.4M 0.01%
344,570
LTC
1617
LTC Properties
LTC
$2.12B
$3.4M 0.01%
+88,434
New +$3.27M
RACB
1618
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
$3.39M 0.01%
345,934
APCA
1619
DELISTED
AP Acquisition Corp
APCA
$3.39M 0.01%
337,852
+3,100
+0.9% +$31K
TRUG icon
1620
TruGolf
TRUG
$969K
$3.38M 0.01%
679
KGC icon
1621
Kinross Gold
KGC
$32.5B
$3.37M 0.01%
941,346
+814,953
+645% +$3.94M
TSLA icon
1622
CALL
Tesla
TSLA
$1.31T
$3.37M 0.01%
15,000
+7,200
+92% +$1.97M
CCTS
1623
DELISTED
Cactus Acquisition Corp. 1 Limited Class A Ordinary Share
CCTS
$3.37M 0.01%
+338,255
New +$3.37M
PDOT.WS
1624
CALL
DELISTED
Peridot Acquisition Corp. II Redeemable warrants included as part of the units, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
PDOT.WS
$3.36M 0.01%
342,956
SFM icon
1625
Sprouts Farmers Market
SFM
$7.96B
$3.36M 0.01%
132,779
+123,665
+1,357% +$3.43M

Similar funds

Marshall Wace's Q2 2022 Portfolio in Review

As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 963 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.

By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.

  • Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
  • Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
  • Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
  • Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
  • Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
  • Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
  • Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.

Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.